Academician
BERRİN ERDAĞ
Profesör
İstanbul Aydın Üniversitesi Tıp Fakültesi Temel Tıp Bilimleri Bölümü
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Biyoloji
Citation impact
Citation counts of the articles matched in OpenAlex, citing publications from Crossref and the Stanford/Elsevier list. Sources are shown separately and never added up.
- i10-index
- 3
- Total citations
- 71 Top 55% in Türkiye
- Per article
- 6.5
- FWCI
- 0.41 1.00 = world average
- World top 1%
- 0
- World top 10%
- 0
Most cited articles
- Phage Displayed HBV Core Antigen with Immunogenic Activity
- Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2
- High microsatellite and mitochondrial diversity in Anatolian native horse breeds shows Anatolia as a genetic conduit between Europe and Asia
How is this computed?
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 2 articles (39 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list. h-index on the OpenAlex author profile: 6.
Citing publications Crossref 3 publications citing 9 DOI-bearing articles · 1 Türkiye-affiliated
- 2020 1
- 2021 2
- Structure‐based engineering of an antiangiogenic scFv antibody for soluble production in E. coli without loss of activity TR Melis Denizci Öncü et al. · Biotechnology and Applied Biochemistry · 2021
- DOI 10.3390/genes12020155 2021
- DOI 10.1016/j.intimp.2020.106760 2020
Where does this list come from?
Extracted from the reference lists in Crossref’s public March 2026 data file; 20.3% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.
Field ranking
Position in the main-field, side-field and keyword cohorts by YÖKSİS article score; each card opens that ranking.
-
Main field Sağlık Bilimleri Temel AlanıPoints rank #25,059/ 39,749 top 63.0% At university #209/ 401Score 5.6 journal 5.6 · OA add 0
- Article rank24,034/39,749
- Scopus rank24,036/39,749
- WoS rank23,846/39,749
- YÖKSİS12
- Scopus6
- WoS6
-
Side field Tıbbi BiyolojiPoints rank #465/ 606 top 76.7% At university #6/ 6Score 5.6 journal 5.6 · OA add 0
- Article rank432/606
- Scopus rank460/606
- WoS rank460/606
- YÖKSİS12
- Scopus6
- WoS6
Works 12
YÖKSİS and OpenAlex records: index distribution, journals published in, a filterable article list and the other output types.
Indexes and citation percentiles
?Other counts
Scopus (SJR)
- YÖKSİS rows 6
WoS (JCR)
- YÖKSİS rows 6
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
9 journals
Narrow down
Article list
- 2025 Therapeutic Peptides Targeting VEGF/VEGFR: Advances in Anti Angiogenic Therapy and the Role of Bioinformatics in Drug Design. European Journal of Biology, 84(2), 231-241. YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 14.6%
- 2023 Cancer Treatment With Peptide Therapeutics YÖKSİS
- 2022 Structure‐based engineering of an antiangiogenic scFv antibody for soluble production in E. coli without loss of activity YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 68.0%
- 2022 Overview of Current Approaches in Cancer Immunotherapy and personalized opportunities for future aspect YÖKSİS OpenAlex 13.1%
- 2021 Structure Based Engineering of an Anti-Angiogenic scFv Antibody for Soluble Production in E. Coli without Loss of Activity YÖKSİS SJR Q3 JCR Q3 OpenAlex 68.0%
- 2021 Identifying specific matrix metalloproteinase-2-inhibiting peptides through phage display-based subtractive screening YÖKSİS TR Index SJR Q2 JCR Q2 OpenAlex 11.7%
- 2020 İnsan RekombinantNano-Antikor Yapılarından Kanser Tanısı ve Tedavisine Yönelik Etken Madde Geliştirilmesi Development of an Active Substance from Human Recombinant Nano-Antibody Constructs For the Diagnosis and Treatment of Cancers YÖKSİS OpenAlex 17.6%
- 2017 Cloning of anti-HBsAg single-chain variable fragments from hybridoma cells for one-step ELISA YÖKSİS SJR Q3 JCR Q4 OpenAlex 58.8%
- 2017 Filamentöz faj üzerinde eksperese edilen Hepatit B yüzey antijenine karşı antikor yanıtı YÖKSİS OpenAlex 21.9%
- 2016 Antibody Response to Hepatitis B Surface Antigen Displayed on Filamentous Phage YÖKSİS
- 2014 Cost effective filamentous phage based immunization nanoparticles displaying a full-length hepatitis B virus surface antigen YÖKSİS OpenAlex 76.7%
- 2012 High microsatellite and mitochondrial diversity in Anatolian native horse breeds shows Anatolia as a genetic conduit between Europe and Asia YÖKSİS SJR Q1 JCR Q1 OpenAlex 58.8%
Projects 15 See all (15) →
-
2014 THE DEVELOPMENT AND PRODUCTION OF A NATIONAL BIOSIMILAR MEDICINES FOR CANCER THERAPY- BIOSIM
-
2015 the development of anti- angiogenic humanized antibodies for inhibiting tumor vascularization, TUBITAK MRC project, 2011-2014, $222.000.İnsana Uyumlu Rekombinant Antikor Yapılarının Nude Fare Tümör Modelinde Tümör Baskılayıcı Etkilerinin İncelenmesi
-
2006 4. Improving The Scientific and Technological Research Capacity of TUBITAK-RIGEB nFunctionals Genomics for Biotechnology BIOCENEX.
-
2017 2. Biyolojik Kimyasal Test Merkezi BKTM projesi, Kalkınma Bakanlığı,
-
2002 Faj gösterim teknolojisi yardımıyla hepatit B Virüs yüzey antijenine karşı rekombinant antikor geliştirilmesi
Books 3
-
2025 Moleküler Tıp alanında özgül bilimsel konular
-
2025 Moleküler Tıp Alanında Özgün Bilimsel Konular
-
2017 Güncel Biyoteknoloji ve Uygulamaları
Proceedings 2
-
2019 Evaluation of cytotoxic and genotoxic effects of three potent water-soluble zinc phthalocyanines
-
2020 The role of synthesis methodology on cytotoxicity properties of dextran-coated nanoceria against cancer cells
Patents 2
-
— Recombinant antibody structures binding to and blocking the activity of vascular endothelial growth factor 2 9193792
-
— Vasküler Endotel Büyüme Faktörüne bağlan ve aktivitesini bloke eden peptit yapılar
Collaboration network
From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.
- Co-authors
- 28
- With an akaturk profile
- 6
- Turkish institutions
- 5
- Co-authored works
- %75
Academic co-authors 6
- CEYDA DURMAZ Öğretim Görevlisi (ders Vermekle Görevli) · İstanbul Aydın Üniversitesi same university 1
- EVREN KOBAN BAŞTANLAR Doçent · Ege Üniversitesi 1
- SEZEN ARAT Profesör · Tekirdağ Namık Kemal Üniversitesi 1
- SONER AKSU Doktor Öğretim Üyesi · İstanbul Sağlık Ve Teknoloji Üniversitesi 1
- ÖZGÜR ASLAN Öğretim Görevlisi (ders Vermekle Görevli) · Kafkas Üniversitesi 1
- ÖZLEM İBRAHİMOĞLU Doçent · İstanbul Medeniyet Üniversitesi 1
National collaboration 5 institutions
Within own university1 joint works · İstanbul Aydın Üniversitesi
- Ege Üniversitesi 1 works · 1 academics
- Kafkas Üniversitesi 1 works · 1 academics
- Tekirdağ Namık Kemal Üniversitesi 1 works · 1 academics
- İstanbul Medeniyet Üniversitesi 1 works · 1 academics
- İstanbul Sağlık Ve Teknoloji Üniversitesi 1 works · 1 academics
Other co-authors (incl. international) 22
AYLİN ÖZDEMİR BAHADIR 8BERTAN KORAY BALCIOĞLU 4Koray Balcioglu 4MÜGE SERHATLI 4HASAN ÜMİT ÖZTÜRK 3AYDIN BAHAR 2AYNUR BAŞALP 2DUYGU HINÇ 2CANDAN TAMERLERDiğdem AktopraklıgilFatima YucelFİLİZ KAYAHAYDAR BAĞIŞHÜLYA SİVASKamil Serkan UzyolM BowerMELİS DENİZCİ ÖNCÜMelis DenizciNURŞAH ERSEZENR BilginİBRAHİM HATİPOĞLUİBRAHİM SÖĞÜT
Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.